BTIM Corp. increased its position in UnitedHealth Group Inc. (NYSE:UNH) by 28.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 221,249 shares of the healthcare conglomerate’s stock after buying an additional 49,531 shares during the period. BTIM Corp.’s holdings in UnitedHealth Group were worth $31,240,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Emerald Acquisition Ltd. bought a new stake in shares of UnitedHealth Group during the second quarter worth $309,266,000. Bank of Montreal Can bought a new stake in shares of UnitedHealth Group during the second quarter worth $207,013,000. Dodge & Cox boosted its stake in shares of UnitedHealth Group by 9.6% in the first quarter. Dodge & Cox now owns 15,183,189 shares of the healthcare conglomerate’s stock worth $1,957,113,000 after buying an additional 1,324,136 shares during the period. Boston Partners boosted its stake in shares of UnitedHealth Group by 47.6% in the second quarter. Boston Partners now owns 3,531,669 shares of the healthcare conglomerate’s stock worth $498,672,000 after buying an additional 1,138,808 shares during the period. Finally, Prudential Financial Inc. boosted its stake in shares of UnitedHealth Group by 47.4% in the first quarter. Prudential Financial Inc. now owns 2,458,710 shares of the healthcare conglomerate’s stock worth $316,927,000 after buying an additional 790,220 shares during the period. Hedge funds and other institutional investors own 85.78% of the company’s stock.

Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.23% during trading on Friday, reaching $140.72. The company had a trading volume of 1,114,899 shares. UnitedHealth Group Inc. has a 12 month low of $107.51 and a 12 month high of $144.48. The firm has a market capitalization of $134.02 billion, a P/E ratio of 22.02 and a beta of 0.57. The firm’s 50 day moving average price is $138.85 and its 200 day moving average price is $135.18.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.89 by $0.07. The firm had revenue of $46.50 billion for the quarter, compared to analysts’ expectations of $45.05 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. Equities analysts predict that UnitedHealth Group Inc. will post $7.92 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were given a $0.625 dividend. This represents a $2.50 annualized dividend and a yield of 1.77%. The ex-dividend date of this dividend was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 39.12%.

A number of equities research analysts recently weighed in on UNH shares. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research note on Sunday, August 21st. Sanford C. Bernstein reiterated an “outperform” rating and issued a $178.00 price target on shares of UnitedHealth Group in a research note on Tuesday, September 6th. Royal Bank Of Canada increased their price target on UnitedHealth Group from $157.00 to $165.00 and gave the company an “outperform” rating in a research note on Wednesday, July 20th. Credit Suisse Group AG reiterated a “buy” rating and issued a $148.00 price target on shares of UnitedHealth Group in a research note on Wednesday, June 29th. Finally, Zacks Investment Research cut UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Monday, July 18th. One research analyst has rated the stock with a hold rating, twenty-four have given a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $154.96.

In related news, Director Richard T. Burke sold 40,000 shares of the business’s stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.65% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.